Price, Mackenzie
Neff, Corey
Kruchko, Carol
Barnholtz-Sloan, Jill S.
Cordeiro, Brittany B.
Penas-Prado, Marta
Ozer, Byram H.
Cimino, Patrick J.
Gilbert, Mark R.
Armstrong, Terri S.
Ostrom, Quinn T.
Funding for this research was provided by:
Centers for Disease Control and Prevention (Contract No.75D30119C06056/Amendment 0003)
Centers for Disease Control and Prevention (Contract No.75D30119C06056/Amendment 0003)
Centers for Disease Control and Prevention (Contract No.75D30119C06056/Amendment 0003)
Centers for Disease Control and Prevention (Contract No.75D30119C06056/Amendment 0003)
American Brain Tumor Association
National Institutes of Health (Contract No.75N91022P00827)
National Institutes of Health (Contract No.75N91022P00827)
National Institutes of Health (Contract No.75N91022P00827)
National Institutes of Health (Contract No.75N91022P00827)
Musella Foundation For Brain Tumor Research and Information
Pediatric Brain Tumor Foundation
Sontag Foundation
Uncle Kory Foundation
National Brain Tumor Society
Zelda Dorin Tetenbaum Memorial Fund
Article History
Received: 12 July 2023
Accepted: 11 October 2023
First Online: 19 November 2023
Declarations
:
: The authors declare no competing interests.
: JSB-S, BBC, BHO, MPP, MRG, and TSA are full-time employees of the NIH/NCI.
: This article does not contain any studies with human participants or animals performed by any of the authors. This study was approved as an exempt study by the Duke University School of Medicine Institutional Review Board.
: This was a retrospective study using de-identified national cancer registries. Thus, formal consent was not required.